Medivolve (Medivolve) Common Stock : $50.15 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Medivolve Common Stock?

Medivolve's quarterly common stock declined from Jun. 2023 ($50.65 Mil) to Sep. 2023 ($49.73 Mil) but then increased from Sep. 2023 ($49.73 Mil) to Dec. 2023 ($50.15 Mil).

Medivolve's annual common stock declined from Dec. 2021 ($52.56 Mil) to Dec. 2022 ($49.53 Mil) but then increased from Dec. 2022 ($49.53 Mil) to Dec. 2023 ($50.15 Mil).

Medivolve Common Stock Historical Data

The historical data trend for Medivolve's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medivolve Common Stock Chart

Medivolve Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

14.37

32.22

52.56

49.53

50.15

Medivolve Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															49.53	49.18	50.65	49.73	50.15

Medivolve Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Medivolve (Medivolve) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medivolve Inc (OTCPK:MEDVF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

4NCA:Germany MEDV:Canada

Address

198 Davenport Road, Toronto, ON, CAN, M5R 1J2

Website

https://www.medivolve.ca

Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.